SMS Pharma Fixes Record Date for AGM and Dividend

SMS Pharmaceuticals Ltd announced the fixation of the record date as September 16, 2026, for determining eligible members to receive dividends for FY 2025-26, subject to AGM approval. The company's 38th Annual General Meeting is scheduled for September 23, 2026. The Board also approved un-audited standalone and consolidated financial results for Q1 FY26, showing a profit before tax of ₹2,814.42 Lakhs. Additionally, the re-appointment of Mr. Ramesh Babu Potluri as Chairman and Managing Director for five years from October 1, 2026, was approved, pending shareholder consent. The company also plans to provide a loan of up to ₹50 Crores to its subsidiary, SMS Peptides Private Limited.